Prime Medicine, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-156.2M | $185.4M |
| FY2022 | — | $316.3M | $187.6M |
| FY2023 | — | $133.1M | $41.6M |
| FY2024 | — | $153.1M | $182.5M |
| FY2025 | — | $120.9M | $63.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-156.2M | $185.4M |
| FY2022 | — | $316.3M | $187.6M |
| FY2023 | — | $133.1M | $41.6M |
| FY2024 | — | $153.1M | $182.5M |
| FY2025 | — | $120.9M | $63.0M |